Spotifit

Medicinal product

(Invented) name

Spotifit

Active substance (s)

Etofenamatas

Strength

50 mg/g

Pharmaceutical form

gelis

Route (s) of administration

vartoti ant odos

Legal status for supply

Nereceptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

M02AA06, Etofenamate

Marketing authorisation holder

SIA Ingen Pharma, Latvija

Date of authorisation

2017-06-07

Date of renewal

2022-01-10

Documents

4085 pakuotes lapelis_2022-01-10.doc

4085 Spotifit_perr2022-01-10, II pr 2022 04 11.docx

Stage

Perregistruotas

Controlled?

No

Controlled substance type

Legal basis

10a

Procedure number

Marketing authorisation procedure

Nacionalinė procedūra

Qualitative and quantitative composition

1 g gelio yra	1 g
Etofenamatas	50 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
68426	83003	1083003	tūbelė	100 g N1		Nereceptinis	LT/1/17/4085/001	Tiekiama	-	-	No	-	-	Download

Stadijos

Data	Stadija
2022-01-10	Perregistruotas
2017-06-07	Registruotas